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Abstract
Background: The small intestine is an important human organ that plays a central role in many physiological functions
including digestion, absorption, secretion and defense. Duodenal pathologies include, for instance, the ulcer associated
to Helicobacter Pylori infection, adenoma and, in genetically predisposed individuals, celiac disease. Alterations in the
bowel reduce its capability to absorb nutrients, minerals and fat-soluble vitamins. Anemia and osteopenia or osteoporosis
may develop as a consequence of vitamins malabsorption. Adenoma is a benign tumor that has the potential to become
cancerous. Adult celiac disease patients present an overall risk of cancer that is almost twice than that found in the
general population. These disease processes are not completely known.
To date, a two dimensional (2D) reference map of proteins expressed in human duodenal tissue is not yet available: the
aim of our study was to characterize the 2D protein map, and to identify proteins of duodenal mucosa of adult individuals
without duodenal illness, to create a protein database. This approach, may be useful for comparing similar protein
samples in different laboratories and for the molecular characterization of intestinal pathologies without recurring to the
use of surgical material.
Results: The enrolled population comprised five selected samples (3 males and 2 females, aged 19 to 42), taken from
20 adult subjects, on their first visit at the gastroenterology unit for a suspected celiac disease, who did not turn to be
affected by any duodenal pathology after gastrointestinal and histological evaluations. Proteins extracted from the five
duodenal mucosal specimens were singly separated by 2D gel electrophoresis. After image analysis of each 2D gel, 179
protein spots, representing 145 unique proteins, from 218 spots tested, were successfully identified by MALDI-TOF ms
analysis. Normalized volumes, for each protein, have been reported for every gel. Proteins have been grouped according
to their biological/metabolic functions.
Conclusion: This study represents to date the first detailed and reproducible 2D protein map of human duodenum.
Spots identifications, reported in a database, will be helpful to identify the variability in protein expression levels, in
isoforms expression, or in post-translational modifications associated to pathology or to a therapy.
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Background
The small intestine is an important human organ and
plays a central role in many physiological functions
including digestion, absorption, secretion and defense.
The mucosa of the small intestine has various structural
features, which considerably increase the luminal surface
area and consequently support the main function of the
small intestine: absorbing the degraded components of
food. The entire intestinal mucosa arranges into two fun-
damental structures: the villi and the crypts of Lieberku-
hun. The surface of the villi is formed predominantly by
mature, absorptive enterocytes, along with occasional
mucus-secreting goblet cells. Each enterocyte presents
numerous microvilli on the luminal plasma membrane.
The crypts of Lieberkuhun are simple tubular glands
around the villi and extend through the lamina propria
down to the muscularis mucosae. They are largely lined
with enteroendocrine cells involved in the secretion of
electrolytes, with Paneth cells releasing antibacterial sub-
stances and with stem cells, which continually divide and
cause the turnover of epithelial cells. Duodenal pathology
include, for instance, ulcer associated to Helicobacter
Pylori, adenoma, cancer, and, in genetically predisposed
individuals, celiac disease (CD). Alterations in the bowel
diminish its capability to absorb nutrients, minerals and
the fat-soluble vitamins A, D, E, and K. Anemia and oste-
openia or osteoporosis may develop as a consequence of
vitamins malabsorption. Adenoma is a benign tumor that
has the potential to become cancerous [1]. Adult CD
patients present an overall risk of cancer that is almost
twice than in the general population. Cancers include T-
and B cell non-Hodgkin's lymphoma and adenocarci-
noma [2]. The mechanisms involved in the development
of these pathologies and in tumor progression are only
partially known.
Proteomics is the study of the complete protein comple-
ment of the cell or the tissue. In contrast with the genome,
the proteome is dynamic and is in constant flux, due to
differential splicing of the respective mRNAs, posttransla-
tional modifications, and temporal and functional regula-
tion of gene expression. The inherent advantage provided
by proteomics is that the identified protein is itself the
biological endpoint expressed into the complexity of the
tissue microenvironment. Proteomics is now entering the
field of biomedicine with declared expectations for the
identification of new pathological markers, therapeutic
targets and markers of therapeutic response. Advances in
the fields of genomics and proteomics will hopefully pro-
vide insights into the molecular complexity of the disease
process, thus enabling the development of tools for treat-
ment as well as for diagnosis and prevention [3-6].
To our knowledge, a 2D gel proteome reference map with
a database of human duodenum expressed proteins, has
not been reported yet. The relative low frequency of duo-
denum routine biopsies, with respect to other anatomical
sites, and the custom to fix biopsies in gastroenterological
practice, have probably delayed the proteomic characteri-
zation of this tissue. Moreover proteomic approaches are
not yet a routine in clinical practice. 2D maps are impor-
tant prerequisites as tissue protein separation and identi-
fication represent important steps to establish the base for
identifying eventual pathological perturbations [7-9]. In
the present study, to contribute to the knowledge on the
biology and physiology of the human small intestine, we
compiled a protein expression profile of the human duo-
denal mucosa. We used the 2D-Difference in Gel Electro-
phoresis (DIGE) since this technique is sensitive and
allows for less than 50 μg of protein to be successfully sep-
arated and detected, compared to the 500 μg required for
a successful traditional Coomassie blue. Moreover, 2D-
DIGE circumvents many of the issues associated with tra-
ditional 2D-PAGE as gel to gel variation and limited
dynamic range, and allows more accurate and sensitive
quantitative proteomic studies [10]. Protein spots have
then been identified with matrix-assisted laser desorp-
tion/ionization-time of flight mass spectrometry (MALDI-
TOF ms) and database searching. A calculation of the
average protein expression levels, the standard deviation
and the coefficient of variation was performed for all iden-
tified proteins. They were then grouped on the base of
their biological functions.
Methods
Patients
For proteomic analyses duodenal biopsies were selected
from five adult subjects, 3 males and 2 females, between
the ages of 19 and 42, on their first visit for a suspected
diagnosis of CD, attending the Gastroenterology Unit of
the Centro di Riferimento Oncologico, IRCCS. Biopsies
were fixed in Bouin solution and a portion of unfixed tis-
sue was snap frozen in liquid nitrogen and stored at -80°C
for proteomic analysis. Histological evaluation, according
to modified Oberhuber-Marsh classification [11],
excluded celiac or other pathological disorders in these
specimens. HLA DQB1 PCR amplification and nucleotide
sequences were carried out as previously reported [12].
Subjects were made aware of the purpose of the study and
an informed consent was obtained from all the enrolled
patients.
Sample preparation for 2D-polyacrylamide gel 
electrophoresis
Proteins were extracted from gut biopsies with Sample
grinding kit (GE Healthcare, Milan, IT) and 200 μl of lysis
buffer containing 7 M urea, 2 M thiourea, 4% CHAPS and
30 mM Tris-HCl pH 8.5. The cell lysates were then pre-
pared for 2D-DIGE with 2D Clean-Up kit (GE Healthcare)Proteome Science 2009, 7:10 http://www.proteomesci.com/content/7/1/10
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and resuspended in 7 M urea, 2 M thiourea and 4%
CHAPS.
Protein concentration was determined with Bio-Rad pro-
tein assay. For DIGE minimal labelling, 25  g of protein
sample were mixed with 100 pmol CyDye (GE Health-
care) and incubated on ice in the dark for 30 min. The
experimental design is reported in Table 1.
Protein samples were then mixed with rehydration buffer
(7 M urea, 2 M thiourea, 4% CHAPS, DTT 40 mM), 0.05%
IPG buffer (Bio-Rad) and a trace amount of Bromophenol
blue. Eleven cm immobilized pH gradient strips [pH 3–10
NL] (Bio-Rad, Milan, IT) were subjected to passive rehy-
dration overnight at room temperature and then run on a
Protean IEF Cell (Bio-Rad) as previously described [13].
Subsequent to the first dimension, and before loading
onto SDS-PAGE gels, IPG strips were equilibrated in 7 M
urea, 2 M thiourea, 2% SDS, 30% glycerol, 50 mM Tris-
HCl pH 8.8), reduced with 65 mM DTT and alkylated with
135 mM iodoacetamide. The second dimension was run
on Criterion IPG + 1 Comb 8–16% precast gels (Bio-Rad).
Gels were scanned on a Typhoon TRIO scanner (GE
Healthcare) at 100 μm resolution. Images were subjected
to Difference In-gel Analysis (DIA) using DeCyder soft-
ware version 6.5 (GE Healthcare) which normalizes and
statistically analyzes protein spots.
Preparative gel has been obtained, through the above
described procedure, but with a 300 μg total protein load.
After 2-DE the gel was fixed in 50% ethanol and 2% orto-
phosphoric acid followed by an exposure to a staining
solution (17%(NH4)2SO4, 2%ortophosphoric acid,
34%methanol). Coomassie Colloidal G-250 was added to
a final concentration of 0.065%. Destaining of the gel was
performed with MilliQ water until the background was
completely clear. Coomassie-stained gel was scanned with
a GS-800 densitometer (Bio-Rad) at 63 μm resolution.
Identification of Protein Spots using MALDI-TOF mass 
spectrometry
Protein spots were excised and destained with 25 mM
ammonium bicarbonate in 50% acetonitrile till the gels
were changed opaque and colorless. After overnight in-gel
trypsin digestion, peptide mixtures were extracted with
1% triflouroacetic acid (TFA), subjected to ZipTip clean-
up (Millipore SPA, Milan, Italy) according to the manu-
facturer's instructions and directly eluted with a α-Cyano-
4-hydroxycinnamic acid matrix (10 g/l α-Cyano-4-
hydroxycinnamic acid in 50% acetonitrile, 0.3% TFA).
MALDI mass spectra were acquired with a Voyager DE Pro
mass spectrometer (Applied Biosystems), in 700–4000 Da
molecular weight range, in reflector and in positive ion
mode, with 150 nsec delay time and an ion acceleration
voltage of 20 kV. Spectra were externally calibrated using
Peptide calibration Mix 4 (Proteomix) 500–3500 Da
(Laser Bio Labs). Mass spectra, obtained by collecting
1000–2000 laser shots, were processed using Data
Explorer version 5.1 software (Applied Biosystems). Peak
lists have been obtained from the raw data following
advanced baseline correction (peak width 32, flexibility
0.5, degree 0.1), noise filtering (noise filter correlation
factor 0.7) and monoisotopic peak selection. Protein
identification has been performed using the MASCOT
search engine http://www.matrixscience.com, Aldente
http://www.expasy.org/tools/aldente and Pro-Found
http://prowl.rockefeller.edu/prowl-cgi/profound.exe pep-
tide mass fingerprinting (PMF) tools.
The NCBInr and Swiss Prot were used as the protein
sequence databases, to produce a standardized probabilis-
tic measure of confidence, limiting the search to human
proteins, allowing for one trypsin missed cleavage and
with a 150 parts per million (ppm) mass tolerance error.
The fixed modification selected was cysteine carbamid-
omethylation, while the variable modification selected
was the methionine oxidation. We included only protein
identifications with a Mowse (MOlecular Weight Search)
score greater than 66 (p < 0.05); the corresponding iden-
tification p-values are reported in Additional file 1.
The protein list has been analyzed with the Pathway
Express tool http://vortex.cs.wayne.edu/projects.htm, or
searched against the Entrez Gene database, to find all
associated pathways. Proteins were then grouped and
listed in relationship to pathways identified.
Average expression of each identified protein
The aim of the majority of 2D gel electrophoresis experi-
ments is to compare two or more different samples to find
changes in protein expression that reflect differences
between the samples being investigated. In this study we
first determined by DeCyder software analysis, normal-
ized volumes for each protein and for each gel tested.
These values have been exported to an Excel worksheet
with the XML toolbox tool of DeCyder software (GE-
Healthcare). Average volume, standard deviation and
coefficient of variation have then been calculated for each
protein spot.
Table 1: 2D-DIGE experimental design
Gel number Cy2 Cy3 Cy5
1 Pooled standard Sample 1 Sample 2
2 Pooled standard Sample 3 Sample 4
3 Pooled standard Sample 5 -
For DIGE minimal labelling, 25  g of protein sample were mixed with 
100 pmol CyDye (GE Healthcare). Every gel included 2 different 
samples, labelled with a different CyDye, and a Cy2-labelled internal 
standard, which is a pool of all the samples within the experiment.Proteome Science 2009, 7:10 http://www.proteomesci.com/content/7/1/10
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Data represent the variation of a single protein expression
in duodenal biopsy from each sample.
Results and Discussion
Our sample comprised five selected individuals, from 20
adult subjects, presented at first visit at the gastroenterol-
ogy unit for a suspected celiac disease. Histological and
HLA analyses do not confirmed celiac disease. Accord-
ingly, duodenal biopsies demonstrated the presence of
normal lymphoid cellularity in the lamina propria, no
epithelial lymphocytosis, and normal architecture of the
villi and crypts.
These samples have then been used to create a human
duodenum reference 2D-map that can provide an initial
framework to facilitate the comparison of diseased and
healthy tissues, or their response to various metabolic,
biochemical, or pharmacological stimuli.
The samples were run according to the experimental
design illustrated in Table 1, and then separately ana-
lyzed.
The included protein spots obtained from all five 2D gels,
ranged from 822 to 1130. All gels were matched to the
duodenum master 2D map and the normal volume of
each protein spot, and for each sample, was determined
by DeCyder software. The Coomassie-stained preparative
gel image was then matched with analytical DIGE gel
images and the visible spots, typically containing enough
protein for mass spectrometry analysis, were selected for
identification. A total of 179 protein spots, representing
145 unique proteins, have been so far positively identified
and are illustrated in Figures 1, 2, 3, 4; quantitative data
are reported on Additional file 2. We failed in identifying
39 spots. As regards faint spots the low protein amount
resulted in low sequence coverage that was not sufficient
for certain identifications. In the remaining 11 spots we
failed in obtaining certain identifications due to the
intrinsic limits of PMF: the possibility to identify only pro-
teins for which sequences are already known and the ina-
bility to detect post-translational modifications and
protein fragments.
For what regards the 179 identified proteins, we used
three search engines for PMF: MASCOT, Aldente and Pro-
Found. The criteria used to accept identifications were the
extent of sequence coverage, the number of matching pep-
tides and a significant probabilistic score, with at least 2
different search engines and/or both the Swiss-Prot and
NCBInr databases. In the few questionable results
(sequence coverage <20% and identification p-values
between 0.001 and 0.05), since we could not make MS/
MS analysis, we applied additional criteria to accept pro-
tein identification: (1) the search engine assignment of
peptide ions must explain most of the non-background
Proteins of human duodenum tissue identified by MALDI- TOF MS from the 2-D gel Figure 1
Proteins of human duodenum tissue identified by 
MALDI-TOF MS from the 2-D gel.
323
436
623
56
563
542
377
1057
581 666
488
558
882
615
48
134
665
701
155
1123
175
534
479 669
697
814
62
683
1094
582
67
1004
289
169
451
487
964
1189
227
643
1174
476
180
49
337
144 229
224
797
288
820
221
620
314
519
605
326
522
149
214
226
397
234
378
657
380
759
1068
282
1015
466
554
10
15
20
25
30
40
50
60
70
80
MW (KDa)
PI 10 0
1054
Proteins of human duodenum tissue identified by MALDI- TOF MS from the 2-D gel Figure 2
Proteins of human duodenum tissue identified by 
MALDI-TOF MS from the 2-D gel.
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Proteins of human duodenum tissue identified by MALDI- TOF MS from the 2-D gel Figure 3
Proteins of human duodenum tissue identified by 
MALDI-TOF MS from the 2-D gel.
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signal (2) the pI and molecular weight of the identified
protein must be consistent with the location in the 2D gel
(3) the mass error of peptide fragments must follow an
internally consistent pattern as for proteins with highly
significant identifications (see Additional file 3). The
detailed data on all identified proteins, clustered by path-
way analysis, are summarized in Additional file 1 while
normal volumes, for all the identified proteins, as well as
their intra-subject variations, are reported in Additional
file 2.
Gel to gel variation due to differences in electrophoretic
conditions, different first dimension strips and second
dimension gels, gel distortions and user to user variations
represent important limits for the use of a generalized pro-
tein map. The normalization of the spot amount is also
questionable as the individual expression profile could be
very changeable and, in addition, extractive and technical
procedures can introduce further quantitative variability.
Despite these limits, a dataset of small intestine proteins
could be of considerable value for future studies aimed at
understanding the molecular bases of small intestine biol-
ogy and pathophysiology. Moreover, the use of 2D-DIGE
technology with the introduction of an internal standard
in every gel, greatly decreases the system variation and
hinders the need of technical replicates. The internal
standard, which is a pool of all the samples within the
experiment, and therefore contains every protein from
every sample, better increases the certainty of data; it is
used to match the protein patterns across gels thereby
excluding the problem of inter-gel variation, a common
problem with standard 2-D assays. To estimate the repro-
ducibility of our 2D gel images, we inserted the data of the
gels of the five patients into one spreadsheet and calcu-
lated the mean, the standard deviation and the coefficient
of variation for each spot (See Additional file 2). Out of
the total 179 protein spots identified, 157 (88%) showed
a coefficient of variation <50%, while only 7 protein spots
(4%) showed a coefficient of variation >70%. Thus, it can
be concluded that most of the proteomic data in this
report represent stable and reproducible data that are
likely to be useful as reference for further studies, and that
the variation observed is mainly due to an individual var-
iability
Moreover, to take a qualitative overview of our proteomic
analysis, we listed the protein spots on the basis of their
involvement in shared biological pathways (See Addi-
tional file 1). Proteins have been clustered as being
involved in metabolic and energetic pathways, in immune
response, in the modulation of cell proliferation and
apoptosis, in protein's families with structural function
and in detoxification reactions.
Among these proteins some are to be mentioned for their
possible role in small intestine pathologies.
To a greater extent, the identified proteins are involved in
carbohydrate, lipid and protein metabolism. The knowl-
edge regarding the control of metabolisms in the small
intestine should be of interest for clinicians involved in
treatment for diabetic or septic patients, or in nutrition
research in humans. They could also be important for the
knowledge of inherited genetic deficiencies, such as glyco-
gen storage disease type 1 (Von Gierke disease) and the
Fanconi-Bickel and glucose-galactose malabsorption syn-
dromes [14].
Twenty-one proteins are related to a structural function.
The presence of a normal mucosal architecture is of fun-
damental importance for small intestine physiology. A
loss of villous height and the consequent atrophic mucosa
are, for example, pathognomonic of coeliac disease,
Crohn's disease, autoimmune enteropathy, lymphoma
and adenocarcinoma [15].
We found 10 proteins related to the peroxisome prolifer-
ator-activated receptor (PPAR) signaling pathway (See
Additional file 1) [16]. The PPARα, -γ, and -β/δ are ligand
activated nuclear receptors with a wide range of effects on
metabolism, cellular proliferation, differentiation, and
the immune response. Of considerable interest, ligands
for PPARγ and PPARα have a therapeutic activity in several
rodent models of inflammatory and autoimmune disease,
suggesting that they might have similar activity in human
disease as well [17]. It has also been shown that the PPARγ
can inhibit the production of several T-cell cytokines,
including the classical TH1-cell cytokine IFN-γ [18],
known to be involved in the autoimmune CD pathogen-
esis [19]. Other proteins are related to immune response
and innate immunity, as immunoglobulin M chains, that
were previously found to be increased in CD [6,20], and
Proteins of human duodenum tissue identified by MALDI- TOF MS from the 2-D gel Figure 4
Proteins of human duodenum tissue identified by 
MALDI-TOF MS from the 2-D gel.
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Charcot-Leyden crystal protein (CLC) that is a lysophos-
pholipase expressed in eosinophils, basophils and in T
lymphocytes [6,21].
We identified several proteins involved in detoxification
reactions, as the glutathione S-transferase (GST) proteins.
The duodenum and jejunum are the main sites of absorp-
tion of xenobiotics and nutrients. Natural nutritional
inducers (for example, flavonoids, indols, allyl sulphides)
enhance the activity of the intestinal GSH system to build
up a protective barrier against noxious agents such as car-
cinogens and electrophilic drugs. Moreover, important
drugs such as insulin, heparin, and cortisol derivatives, as
well as vegetable diets, enhance GSTP and GSTA levels.
GSTA and GSTP expression levels can then represent a
marker to monitor the response of the differentiated
mature function of the mucosal enterocytes to specific
exogenous factors [22].
Five proteins are involved in apoptosis/survival pathways:
phosphatidylethanolamine-binding protein 1 (PEBP1,
spot 882), also known as Raf kinase inhibitory protein
(RKIP), MGC29506 (spot 964), Ras-related nuclear pro-
tein (Ran) (spot 814), 14-3-3 protein zeta/delta (spot
762) and galectin-3 (spot 765).
Among them, the PEPB1 and RAN proteins were particu-
larly interesting for their involvement in cancer develop-
ment.
PEBP1, an endogenous inhibitor of the Raf-MAPK kinase
(MEK)-MAP kinase pathway, has emerged as a significant
metastasis suppressor in a variety of human cancers,
including colorectal cancer, and was recently shown to
regulate the spindle checkpoint in cultured cells [23].
RAN is a small GTP binding protein belonging to the RAS
superfamily that is essential for the translocation of RNA
and proteins through the nuclear pore complex. The RAN
protein is also involved in the control of DNA synthesis
and cell cycle progression and also in the signal transduc-
tion pathway determining NF-kB-inducing kinase (NIK)-
mediated NF-kB activation [24]. Recently RAN was dem-
onstrated to be broadly overexpressed in cancer [25] as
well as in damaged non neoplastic tissue as in CD patients
with histological Marsh-III grade [26].
Other proteins, identifiable by 2DE, could also be impor-
tant for the study of the small intestinal tumors, as the
Galectin-3 and the HMGCS2 protein. Galectin-3 protein
is known to enhance cell resistance to a variety of apop-
totic stimuli [27] and, in colon cancer, increased levels of
galectin-3 correlate with neoplastic progression [28].
HMGCS2 protein expression is down-regulated preferen-
tially in moderately and poorly differentiated carcinomas.
In addition, it is also down-regulated in 80% of small
intestine Myc-independent tumors [29].
Conclusion
The small intestine is an organ with a wide variety of func-
tions, including not only nutrient absorption but also a
protective response against antigenic and toxic com-
pounds (or organisms) present in food. Proteomics can
offer an unbiased approach to investigate global changes
in protein expression. The analysis of biopsy specimens by
proteomic technology might be useful for analysing pre-
operative samples for diagnosis or for determining
pathology sensitivity to therapy.
Our data, obtained by a 2-DIGE approach combined with
MALDI-TOF ms protein identification and the use of soft-
ware for protein functional research, illustrate the pro-
teome of the normal duodenal mucosa. This dataset may
be helpful in future proteomic studies, to a deeper knowl-
edge of the mechanisms of intestinal disease pathogene-
sis, and may also help in finding new disease-specific
biomarkers. Moreover, even if five determinations have
low statistical significance, in a large series of the reported
protein (88%), the protein expression values proved to be
reproducible and stable enough to be used as reference for
further studies. Finally, the 2D-gel image could be
included into a Web database with active maps (e.g.,
SWISS-2DPAGE); this will consent to identify the protein,
if this is reported in the database, by simply clicking a spot
in the active gel image.
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